BSECompany UpdateMgmt Change13 Aug 2026
Granules India Ltd-$
Change in Senior Management Personnel (SMP) of the Company
Granules India Ltd has announced the internal transfer of Mr. Sanjay Kumar, Chief Strategy Officer, to its wholly owned subsidiary Ascelis Peptides Private Limited, effective August 13, 2026.
BSEAGM/EGMResults6 Aug 2026
Granules India Ltd-$
Scrutinizer''s report for the 35th AGM
Granules India Ltd. held its 35th Annual General Meeting (AGM) on August 6, 2026, through video conferencing. The meeting was attended by 67 members, including directors and representatives. The AGM adopted the standalone and consolidated audited financial statements for FY 2025-26, declared a final dividend of Rs. 1.75 per equity share, and re-appointed Ms. Priyanka Chigurupati as a director. The Scrutinizer's report on remote e-voting and voting results was also presented.
BSEAGM/EGMResults6 Aug 2026
Granules India Ltd-$
Outcome of 35th Annual General Meeting of the Company
Granules India Ltd held its 35th Annual General Meeting on August 6, 2026, through video conferencing, with 67 members in attendance. The meeting adopted the standalone and consolidated audited financial statements for FY 2025-26, declared a final dividend of Rs. 1.75 paise per equity share, and re-appointed Ms. Priyanka Chigurupati as a director.
BSEInsider Trading / SASTRegulatory4 Aug 2026
Granules India Ltd-$
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
Granules India Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Life Insurance Corporation of India.
BSECompany Update▲ PositiveResults27 Jul 2026
Granules India Ltd-$
Transcript of the earnings call for Q1 of FY27
Granules India Ltd reported its Q1 FY27 earnings, with revenue growing 22% YoY to INR1,477 crores, gross margin at 65.6%, EBITDA growing 37% to INR339 crores, and profit after tax growing 60% to INR180 crores. The company's return on capital improved to 18% and net debt to EBITDA is 0.07x, making it debt-free for practical purposes.
BSECompany UpdateResults22 Jul 2026
Granules India Ltd-$
Audio Recording of the Investor Call
Granules India Ltd has announced the audio recording of its investor call for FY27 earnings conference. The recording is available on the company's website.
BSECompany UpdateFundraise21 Jul 2026
Granules India Ltd-$
Monitoring Agency report for the quarter ended on June 30, 2026
Granules India Ltd has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as required by SEBI regulations, detailing the utilization of proceeds from a Preferential Issue.
BSECompany Update▲ PositiveResults21 Jul 2026
Granules India Ltd-$
Investor Presentation for Q1 of FY27
Granules India Ltd has reported a 22% YoY growth in revenue to ₹14,768 Mn, with PAT increasing by 60% YoY to ₹1,800 Mn and EBITDA by 37% YoY to ₹3,389 Mn. The company's Complex Gx mix has increased to 50% of its FD portfolio, lifting gross margin to 65.6% and EBITDA margin to 22.9% (+256 bps YoY). Net Debt/EBITDA has improved to 0.07x from 0.34x, and ROCE has increased to 18.0% (+196 bps YoY) on ₹3,874 Mn cash flow from operations.
BSECompany Update▲ PositiveResults21 Jul 2026
Granules India Ltd-$
Press Release for Q1 of FY27
Granules India Ltd. has announced its Q1FY27 financial results, with revenue from operations at INR 14,768 Mn, up 22% YoY, EBITDA at INR 3,389 Mn, up 37% YoY, PBT before Exceptional Item at INR 2,404 Mn, up 41% YoY, and PAT at INR 1,800 Mn, up 60% YoY.
BSEBoard MeetingResults21 Jul 2026
Granules India Ltd-$
Outcome of the Board Meeting Dated July 21, 2026
Granules India Ltd has announced its unaudited financial results for the first quarter ended June 30, 2026, with revenue from operations at ₹8,018.77 crore and a net profit of ₹8,156.61 crore.